International Briefs: Australia’s IVD Framework; NICE Supports Two Devices
This article was originally published in The Gray Sheet
Abbott weighs in on proposed amendments to Australia’s in vitro diagnostics regulatory framework. NICE gives thumbs-up to intubation and amniotic fluid leak detection devices.
You may also be interested in...
Recent meeting of the International Medical Device Regulators Forum draws a big audience. Two devices receive draft support from the U.K.'s National Institute for Health and Clinical Excellence.
Public Company Edition: Cancer-focused Adlai Nortye launched a concurrent initial public offering and private placement, while four other drug developers announced or completed SPAC mergers. Also, Sobi grossed $540m in a rights issue and Immunovant followed early data with a $450m FOPO.
The company anticipates potential sales in excess of $1bn for the late-onset Pompe disease drug by the end of the decade.